The EGF receptor family comprises several related receptor tyrosine kinases that are frequently overexpressed in a variety of carcinomas. Upregulation of EGFR is associated with tumor progression. Abrogation of EGFR may be achieved with the use of EGFR Inhibitors with potential results in cell cycle arrest, apoptosis or dedifferentiation of cancer cells. EGFR Substrates offered by Santa Cruz affects EGFR and, in some cases, other receptor tyrosine kinases and tumor progression related proteins. View detailed EGFR Substrate specifications, including EGFR Substrate CAS number, molecular weight, molecular formula and chemical structure, by clicking on the product name.

製品名/アプリケーション CAS カタログ # 数量 価格 引用文献 レーティング
pp60v-src Autophosphorylation Site, Tyrosine Kinase Substrate
pp60v-src Autophosphorylation Site, Tyrosine Kinase Substrate is a tyrosine kinase substrate with ability to phosphorylate
81493-98-3 sc-201165
1 mg
EGFR Substrate
0.5 mg/0.1 ml

サンタクルーズバイオテクノロジーは生物医学研究市場向けの製品の開発における世界的リーダです。 下記フリー ダイヤルにお電話ください: 1-800-457-3801。Copyright © 2007-2020 Santa Cruz Biotechnology, Inc.全著作権所有。"Santa Cruz Biotechnology"、 及びSanta Cruz Biotechnology, Inc. ロゴ、 "Santa Cruz Animal Health"、 "San Juan Ranch"、 "Supplement of Champions"、 San Juan Ranch ロゴ、 "Ultracruz"、 "Chemcruz"、 "Immunocruz"、 "Exactacruz"、 と "EZ Touch"はサンタクルーズバイオテクノロジーの登録商標です。 商標はそれぞれの所有者に帰属します。